CME Group Inc (CME) Stock Analysis
Verdict: HOLD
CME offers a defensive moat and high margins, but legal battles over crypto perpetuals and significant insider selling create a short-term drag.
Investment score: 62/100
Analysis as of
Is CME Group Inc stock worth reviewing? AI model thesis
Wait for technical stabilization.
7-factor investment score
- Valuation: 72/100 (weight 20%)
- Financial Health: 88/100 (weight 15%)
- Technical Momentum: 35/100 (weight 15%)
- Earnings Quality: 55/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 68/100 (weight 10%)
- Risk-Adjusted Return: 75/100 (weight 15%)
CME Group Inc opportunities and risks
What speaks for CME
- Interest Rate Volatility Moat
What speaks against CME
- Regulatory & Legal Setback (CFTC Suit)
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| CME | 20.9x | 13.2x | 15.1x | 86.3% | 62.8% | 4.8% |
| SPGI | 25.6x | 7.7x | 16.4x | 70.5% | 30.4% | 4.6% |
| MCO | 31.9x | 10.0x | 21.4x | 69.7% | 31.7% | 3.8% |
| ICE | 19.4x | 5.8x | 14.4x | 69.0% | 30.0% | 6.0% |
| NDAQ | 24.4x | 5.6x | 17.8x | 54.8% | 23.1% | 4.3% |
| Peer median | 25.0x | 6.8x | 17.1x | 69.3% | 30.2% | 4.4% |
Frequently asked questions about CME Group Inc (CME)
Is CME stock a good investment?
The cached TradeMates AI model rates CME Group Inc as HOLD with an investment score of 62/100. Wait for technical stabilization. This is algorithmic model output, not personal investment advice.
Is CME stock a buy?
The TradeMates model verdict for CME is HOLD with an investment score of 62/100. Treat this as a model signal to review, not a personal buy recommendation.